Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PDE4DIP | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | TLE1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | PIGT | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | ARFIP2 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | CRADD | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | POLR2M | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | CINP | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | TAS2R41 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | ATF7IP | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | PLCH2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |